A complete application in a minute
Tailored resume and cover letter, ready to send.
KU Leuven invites applications for a funded PhD in collaboration with VITO and PanTera to develop radionuclide generator technology. You will pursue the doctorate under Prof.
Thomas Cardinaels, conducting experimental work primarily at VITO Mol in Belgium and collaborating with KU Leuven and PanTera. The project targets ²²⁵Ac/²¹³Bi generators, addressing material stability, flow-through separation and high-purity ²¹³Bi recovery under challenging conditions.
This PhD is a joint collaboration between KU Leuven, VITO and PanTera, combining academic research, applied technological development and industrial expertise in radionuclide production.
You will pursue your doctorate at KU Leuven under the academic supervision of Prof. Thomas Cardinaels. The experimental research will be conducted primarily at VITO in Mol, Belgium, in close collaboration with KU Leuven and PanTera, which funds the project.
This setting offers the opportunity to work across institutional and disciplinary boundaries, connecting fundamental insights into materials and separation chemistry with the practical requirements of radionuclide generator technology.
Targeted alpha therapy uses radionuclides to deliver radiation selectively to cancer cells, aiming to maximise therapeutic impact while limiting damage to surrounding healthy tissue. Among the radionuclides relevant to this approach, ²¹³Bi offers a short‑lived, complementary option to the longer‑lived ²²⁵Ac. A ²²⁵Ac/²¹³Bi generator allows fresh ²¹³Bi to be recovered on demand from a source of ²²⁵Ac. Its performance depends critically on the stationary phase: the material must retain ²²⁵Ac effectively while enabling rapid and reproducible recovery of high‑purity ²¹³Bi. It must also withstand demanding operating conditions, including strongly acidic environments and prolonged exposure to ionising radiation. Although various sorbent materials have been investigated, chemical and radiation stability remain important challenges. Moreover, promising results obtained with powders do not necessarily translate into reliable performance under flow conditions in an operational generator.
Your PhD will bridge this gap between functional materials and working separation systems.
You will work closely with researchers across the partner organisations and communicate your findings through scientific publications, presentations and a doctoral thesis.
We are looking for a curious and committed researcher who enjoys combining fundamental understanding with hands‑on experimental work.
We offer a funded PhD opportunity with clear societal relevance, focused on developing enabling technology for targeted alpha therapy.
You will benefit from the complementary expertise of a university, an applied research organisation and an industrial partner active in radionuclide production. The project provides an opportunity to build a distinctive research profile spanning materials development, surface functionalisation, radiochemistry and separation technology.
Your work will connect fundamental scientific questions with practical technological challenges, with the ambition of contributing to more reliable and accessible production of ²¹³Bi for targeted alpha therapy.
For further information about the project, please contact Prof. Thomas Cardinaels, mail to: thomas.cardinaels@kuleuven.be.
KU Leuven strives for an inclusive, respectful and socially safe environment. We embrace diversity among individuals and groups as an asset. Open dialogue and differences in perspective are essential for an ambitious research and educational environment. In our commitment to equal opportunity, we recognize the consequences of historical inequalities. We do not accept any form of discrimination based on, but not limited to, gender identity and expression, sexual orientation, age, ethnic or national background, skin colour, religious and philosophical diversity, neurodivergence, employment disability, health, or socioeconomic status. For questions about accessibility or support offered, we are happy to assist you at this email address.